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he NHPX protein is a nucleolar factor that binds
directly to a conserved RNA target sequence found
in nucleolar box C/D snoRNAs and in U4 snRNA.
Using enhanced yellow fluorescent protein (EYFP)– and
enhanced cyan ﬂuorescent protein–NHPX fusions, we
show here that NHPX is speciﬁcally accumulated in
both nucleoli and Cajal bodies (CBs) in vivo. The fusion
proteins display identical localization patterns and RNA
binding speciﬁcities to the endogenous NHPX. Analysis
of a HeLa cell line stably expressing EYFP–NHPX showed
that the nucleolar accumulation of NHPX was preceded by
its transient accumulation in splicing speckles. Only newly
T
 
expressed NHPX accumulated in speckles, and the nucleolar
pool of NHPX did not interchange with the pool in speckles,
consistent with a unidirectional pathway. The transient
accumulation of NHPX in speckles prior to nucleoli was
observed in multiple cell lines, including primary cells that
lack CBs. Inhibitor studies indicated that progression of
newly expressed NHPX from speckles to nucleoli was
dependent on RNA polymerase II transcription, but not on
RNA polymerase I activity. The data show a speciﬁc temporal
pathway involving the sequential and directed accumulation
of NHPX in distinct subnuclear compartments, and deﬁne a
novel mechanism for nucleolar localization.
 
Introduction
 
The cell nucleus is the site at which chromosomes are lo-
cated, and at which DNA replication and gene expression are
 
coordinated and regulated. Many nuclear factors are organized
into specific structures termed nuclear bodies (for review see
Lamond and Earnshaw, 1998; Schul et al., 1998; Matera,
1999; Spector, 2001). Most nuclear bodies are dynamic, disas-
sembling on entry to M phase and reassembling after mitosis
(Dundr et al., 2000). Unlike cytoplasmic organelles, nuclear
bodies are not enclosed by membranes. Factors can move in
and out of nuclear bodies (for review see Misteli, 2001), and
the bodies themselves can also move within the nucleoplasm
(Boudonck et al., 1999; Platani et al., 2000; Snaar et al.,
2000; Muratani et al., 2001).
The best-studied subnuclear body is the nucleolus (for
reviews see Pederson, 1998; Scheer and Hock, 1999;
Carmo-Fonseca et al., 2000; Olson et al., 2000; Visintin and
Amon, 2000). Whereas 
 
 
 
10% of protein-coding genes are
active at any time, 
 
 
 
80% of the total cellular transcription
activity is devoted to expression of the conserved ribosomal
DNA (rDNA)* repeats in nucleoli by RNA polymerase I
(Blobel and Potter, 1967). Multiple rDNA transcription
units are joined together by nontranscribed intergenic spaces
to form the so-called nucleolar organizing regions (NORs)
located in human chromosomes 13, 14, 15, 21, and 22. Nu-
cleoli are assembled on these chromosomal NOR regions af-
ter every round of mitosis. The rDNA-containing region is
transcribed to yield a precursor, the 45S pre-rRNA, which is
processed in a series of posttranscriptional cleavage and
modification reactions to generate mature rRNA species that
form the catalytic core of the ribosome (for review see
Warner, 2001). Various small nucleolar RNAs (snoRNAs),
for example U3 and U14, are needed for these separate
rRNA cleavage steps, each snoRNA being required at spe-
cific steps. The snoRNAs can be categorized into two main
classes, box C/D (i.e., U3, U8, U14) and box H/ACA (i.e.,
U17, U19, U64), according to conserved sequence elements
and the way in which they are assumed to fold into defined
secondary structures (for review see Weinstein and Steitz,
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1999). These snoRNAs assemble together with protein fac-
tors to form snoRNPs that have roles in guiding and cata-
lyzing posttranscriptional RNA modifications. For exam-
ple, box C/D snoRNPs direct 2
 
 
 
-
 
O
 
-ribose methylation and
box H/ACA snoRNPs direct pseudouridylations of specific
rRNA nucleotides (for review see Lafontaine and Tollervey,
1998; Lewis and Tollervey, 2000).
Several nucleolar proteins, including the snoRNP factor
fibrillarin, have been found in Cajal bodies (CBs) (for review
see Gall, 2000). These subnuclear structures, originally called
nucleolar accessory bodies, or coiled bodies, are often associ-
ated with the nucleolar periphery, or even located inside the
nucleolus (Malatesta et al., 1994; Ochs et al., 1994; Lyon et
al., 1997; Sleeman et al., 1998). In addition to snoRNPs, they
also contain splicing snRNPs and some transcription factors;
however, they do not contain non-snRNP protein splicing
factors or nascent pre-mRNA. Their snRNP components are
specifically newly assembled particles (Carvalho et al., 1999;
Gall et al., 1999; Sleeman and Lamond, 1999a; Sleeman et
al., 2001). Fluorescently labeled U3, U8, and U14 snoRNAs,
when microinjected into 
 
Xenopus
 
 oocytes, accumulate tran-
siently in CBs prior to nucleoli, suggesting that newly im-
ported snoRNAs flow from the CBs to nucleoli (Narayanan et
al., 1999b). Therefore, CBs might be involved in transport
and maturation of both snRNPs and snoRNPs.
In higher eukaryotes, most pre-mRNAs must be spliced
to generate functional mRNAs. Splicing is a nuclear pro-
cess carried out by a complex RNA protein machine
termed the spliceosome (for review see Staley and Guth-
rie, 1998). Although splicing often occurs cotranscrip-
tionally, the majority of pre-mRNA splicing factors are
not localized at active transcription sites; instead, they are
enriched in domains called speckles (for reviews see Slee-
man and Lamond, 1999b; Misteli, 2000). Recruitment of
splicing factors to sites of transcription is believed to in-
volve a cycle of phosphorylation and dephosphorylation
(for review see Misteli, 1999).
The advent of green fluorescent protein (GFP) technology
allows the visualization of tagged proteins and their move-
ment in living cells (for review see Swedlow and Lamond,
2001). The use of photobleaching techniques with the GFP
fusion proteins also allows analysis of protein dynamics (Phair
and Misteli, 2001; Reits and Neefjes, 2001). Here we describe
a novel nuclear pathway shown by the nucleolar factor
NHPX. The NHPX protein was recently identified as a puta-
tive human homologue of yeast NHP2p (Saito et al., 1996),
and later, independently, as a 15.5-kD RNA-binding protein
(Nottrott et al., 1999). Subsequent analyses indicated that
NHPX is the human orthologue of the 
 
Saccharomyces cerevi-
siae
 
 Snu13p (Chang et al., 1999; Nottrott et al., 1999). The
human NHPX protein was also independently identified in a
directed proteomic analysis of nucleoli isolated from cultured
HeLa cells (Andersen et al., 2002); it shares a common RNP
structure that binds to both box C/D snoRNAs and spliceoso-
mal U4 snRNA (Nottrott et al., 1999; Vidovic et al., 2000;
Watkins et al., 2000). However, NHPX localizes in nucleoli
by immunofluorescence (Chang et al., 1999). Here we ana-
lyze the in vivo pathway by which NHPX accumulates in nu-
cleoli, and show that it involves an unexpected, transient in-
teraction with splicing speckles. The movement of NHPX
 
from speckles to nucleoli is dependent on pre-mRNA tran-
scription. These data suggest that NHPX may be involved in,
and possibly link, several parallel RNA metabolic pathways
that occur in distinct nuclear domains.
 
Results
 
NHPX is localized to nucleoli and CBs
 
NHPX was selected for characterization as part of the anal-
ysis of the human nucleolar proteome (Andersen et al.,
2002). To address its in vivo localization, the NHPX
cDNA was isolated from a HeLa cDNA library and tagged
at its NH
 
2
 
 terminus with the enhanced yellow fluorescent
protein (EYFP) gene to generate plasmid pAL107
 
EYFP–NHPX
 
(see Materials and methods). The localization of the EYFP–
NHPX fusion protein was analyzed by fluorescence micros-
copy after transient transfection of pAL107
 
EYFP–NHPX
 
 in
HeLa cells (Fig. 1), and compared with the nucleolar pro-
tein fibrillarin (FIB). Transiently expressed EYFP–NHPX
was colocalized with FIB in the dense fibrillar component
of nucleoli and also, unexpectedly, in CBs. (Fig. 1 A, arrow
indicates nucleolus, arrowhead indicates CB). The CB lo-
calization was confirmed by counterstaining with anti-coi-
lin antibodies (Fig. 2 A; unpublished data). The localiza-
tion of NHPX to CBs and nucleoli was also confirmed
by immunofluorescence (Figs. 1 B and S1, available at
http://www.jcb.org/cgi/content/full/200201120/DC1). The
tagged NHPX showed an identical localization to its endog-
enous counterpart, suggesting that NHPX is a component
of both nuclear structures (Fig. 1 B).
To facilitate in vivo analysis of NHPX, we established a
HeLa cell line stably expressing EYFP–NHPX (see Materials
and methods). As shown by fluorescence microscopy, the
EYFP–NHPX protein localized specifically in nucleoli and
CBs in the HeLa
 
EYFP–NHPX
 
 stable cell line (Fig. 2). The
HeLa
 
EYFP–NHPX
 
 cell line grows and divides at the same rate as
the parental HeLa cell line without any apparent cell cycle
defect, as shown by FACS analysis (Fig. 1 C; unpublished
data). The expression level of EYFP–NHPX is comparable
to that of the endogenous NHPX protein in the HeLa
 
EYFP–
NHPX
 
 cell line (Fig. 1 D).
To confirm that the EYFP–NHPX fusion protein expressed
in the HeLa
 
EYFP–NHPX
 
 cell line behaves biochemically as the en-
dogenous protein, its in vivo RNA-binding specificity was in-
vestigated. An extract from HeLa
 
EYFP–NHPX
 
 cells was immu-
noprecipitated using an anti-GFP antibody. RNAs in the
immunoprecipitate were separated by Urea-polyacrylamide gel
electrophoresis, transferred to nylon membrane, and hybridized
with probes for U1, U2, U4, U5, and U6 snRNAs and U3
snoRNA (Fig. 1 E). This showed that U3 snoRNA and U4 sn-
RNA, but not U1, U2, U5, or U6 snRNAs, were preferentially
isolated with the anti-GFP antibody (Fig. 1 E, lane 3). Control
experiments, i.e., bead control and an HeLa
 
EGFP–H2B
 
 cell ex-
tract, showed that although the anti-GFP antibody still pulled
down the fluorescent protein fusion protein (unpublished
data), it did not pull down any of the RNAs tested from these
extracts (Fig. 1 E, lane 1 and 2), whereas the same anti-GFP an-
tibody pulled down each of the U1, U2, U4, U5, and U6 sn-
RNAs, but not U3 snoRNA, from a HeLa
 
ECFP–SmB
 
 cell extract
(Fig. 1 E, lane 4). These data show that the EYFP–NHPX fu- 
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Figure 1. Transient and stable expression of EYFP–NHPX in HeLa cell line. HeLa cells transiently transfected with pAL107
EYFP–NHPX for 16 h 
were fixed and counterstained with (A) anti-FIB antibody 72B9 and (B) affinity-purified anti-NHPX serum R86. Arrowhead indicates CB and 
arrow indicates nucleolus. (C) DNA content of HeLa
EYFP–NHPX cells were analyzed by FACS analysis and (D) its expression level by immunoblot 
using antiserum R86 and anti-GFP. (E) The in vivo RNA binding activity of EYFP-NHPX was assayed by immunoprecipitation and the binding 
of snRNAs U1, U2, U4, U5, and U6 as well as snoRNA U3 were tested by Northern hybridization. Bars, 5  m. 
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Figure 2. Localization of NHPX during interphase and mitosis. The patterns of EYFP–NHPX in HeLa
EYFP–NHPX were analyzed (A) during interphase 
and (B) in different stages of mitosis. Anti-coilin 204/10 was used to denote CBs, anti-SC35 to denote speckles and DAPI to show the condensed 
chromosome in mitotic stages. Arrowhead indicates CB, arrow indicates nucleolus, and broken arrow indicates speckles. (C) The pattern of 
EYFP–NHPX in HeLa
EYFP–NHPX during mitosis was followed after metaphase in a live cell imaged every 3 min. Bars, 5  m.
 
and U6 snRNAs usually exist as a duplex inside the nucleus, the
immunoprecipitation of U4 snRNA alone is surprising. The
disruption of the U4/U6 interaction in this assay is unlikely,
sion protein in vivo is specifically complexed with the same
RNA targets that NHPX was shown to bind directly in vitro
(Nottrott et al., 1999; Watkins et al., 2000). Given that U4 
 
 
Novel nucleolar localization pathway for NHPX |
 
 Leung and Lamond 619
 
because a non-Sm RNA, i.e., U6 snRNA, can be coimmuno-
precipitated with U4 from the ECFP–SmB cell extract under
the same experimental conditions and using the same anti-GFP
antibody (Fig. 1 E, lane 4). Another interesting observation is
that only a small amount of the total U4 snRNA was pulled
down in these experiments (Fig. 1 E, lane 3), even though U4
snRNA is present in similar abundance to U3 snoRNA inside
HeLa cells (Reddy and Bush, 1988). This suggests that only a
subset of U4, which is likely not bound to U6, may be interact-
ing with NHPX in vivo. Alternatively, the fraction of NHPX
bound to the U4/U6 duplex could be inaccessible to the anti-
GFP antibodies.
 
NHPX is colocalized with U3-containing snoRNPs, 
rather than U4-enriched splicing speckles,
during interphase
 
The ability of NHPX to bind both U3 snoRNA and U4
snRNA, which normally are located in different subnuclear
structures, prompted us to investigate further the localiza-
tion of NHPX under different conditions (Fig. 2). The
binding of NHPX to the spliceosomal U4 snRNA suggests
that it should colocalize, at least in part, with other splicing
factors. However, EYFP–NHPX in the HeLa
 
EYFP–NHPX
 
 cell
line does not show a speckled nuclear pattern similar to
other human splicing factors such as SC35 and U1A (Fig.
2 A, arrowhead indicates CB, arrow indicates nucleolus,
broken arrow indicates speckles). The anti-NHPX antise-
rum also does not label speckles (Fig. 1 B, Chang et al.,
1999). Instead, EYFP–NHPX is accumulated in nucleoli
and CBs and colocalizes with the snoRNP protein FIB
(Figs. 1 A and 2 A ; unpublished data). Also, nucleolar
segregation, caused by treating the cells with the transcrip-
tion inhibitor actinomycin D, results in the relocation of
NHPX to the nucleolar periphery along with FIB, but does
not cause it to colocalize with either SC35, or other splic-
ing factors (unpublished data).
Figure 3. NHPX transiently accumulates 
in splicing speckles. Microinjection of 
pAL107
EYFP–NHPX into (A) transformed 
cell line MCF7 and (B) primary fibroblast 
htert1787. The microinjected cells 
were fixed at different time points (1 h, 
6 h and 16 h) and counterstained with 
anti-SC35 to denote speckles and 
anti-coilin 204/10 to denote CBs. 
Arrowheads indicate CBs, arrows 
indicate nucleoli and broken arrows 
indicate speckles. Bars, 5  m. 
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Analysis of the HeLa
 
EYFP–NHPX
 
 cells at different stages of
mitosis also showed no evidence for the association of
NHPX with splicing factors (Fig. 2 B). Time-lapse analysis
of live HeLa
 
EYFP–NHPX
 
 cells showed that NHPX associated
with snoRNP-containing nucleoli immediately after the nu-
clear envelope reforms (Fig. 2 C; unpublished data). Com-
bined with other immunofluorescence data of fixed cells
counterstained with anti-FIB (unpublished data), we con-
clude that EYFP–NHPX does not accumulate with snRNPs
in speckles, but instead colocalizes with the snoRNP protein
FIB at all cell cycle stages and metabolic conditions tested.
The only colocalization of NHPX with splicing snRNPs de-
tected in vivo was specifically in CBs, structures known to
accumulate newly imported snRNPs and snoRNPs when
they first enter the nucleus.
 
Newly imported NHPX transiently colocalizes 
with splicing factors
 
Next, we investigated the localization of newly synthe-
sized NHPX because recent data have shown a temporal
pathway for snRNP and snoRNP localization in nuclei
(Fig. 3; Carvalho et al., 1999; Narayanan et al., 1999a,
1999b; Sleeman and Lamond, 1999a; Sleeman et al.,
2001). To our surprise, microinjection of the expression
vector pAL107
 
EYFP–NHPX
 
 into the cultured cell lines, fol-
lowed by examination in the fluorescence microscope, re-
vealed that 1 h after microinjection, EYFP–NHPX is ac-
cumulated in splicing speckles and CBs (Fig. 3). 2–6 h
postmicroinjection, EYFP–NHPX is also detected in nu-
cleoli, whereas the level of EYFP–NHPX in speckles
shows a concomitant decrease. At later time points, the
signal in speckles can no longer be detected and EYFP–
NHPX accumulates specifically in nucleoli and CBs, re-
sembling the pattern observed in the HeLa
 
EYFP–NHPX
 
 cell
line during interphase.
This novel nuclear pathway for NHPX was observed not
only in parental HeLa cells, but also when newly synthesized
EYFP–NHPX was expressed after either microinjection or
transient transfection in other transformed cell lines, in-
cluding MCF7 (Fig. 3 A, arrowhead indicates CB, arrow
indicates nucleolus, broken arrow indicates speckles) and
HEK293 and in primary cell lines, i.e., human foreskin fi-
broblasts and primary human fibroblasts expressing telom-
erase htert1787 (Fig. 3 B; unpublished data). Some cell
lines, i.e., htert1787, do not contain prominent CBs, and
therefore provide an opportunity to test whether the pres-
ence of CBs is required for the transport and/or localization
of NHPX in nucleoli. Microinjection of pAL107
 
EYFP–NHPX
 
into htert1787 cells did not induce the formation of CBs,
and EYFP–NHPX still relocated in the same temporal se-
quence from speckles to nucleoli (Fig. 3 B, arrow indicates
nucleolus, broken arrow indicates speckles). Therefore, the
presence of CBs is apparently not required for the direc-
tional movement of NHPX from speckles to nucleoli.
 
Newly synthesized NHPX does not colocalize with U3 
snoRNP in speckles
 
Next, we examined whether the speckle localization of newly
synthesized NHPX is a consequence of a previously un-
known behavior of U3 snoRNP. To test this, an expres-
sion vector, pAL118
 
ECFP–FIB
 
, encoding ECFP-tagged FIB, a
known U3 snoRNP component, was cotransfected with
pAL107
 
EYFP–NHPX
 
 into the parental HeLa cell line and ana-
lyzed at various time points posttransfection (Fig. 4). At 1 h
posttransfection, ECFP–FIB had already accumulated in
nucleoli and CBs, whereas in the same cells, EYFP–NHPX
accumulated in speckles and CBs, but not in nucleoli (Fig. 4
A, arrow indicates nucleolus, broken arrow indicates speck-
les). Several hours later, EYFP–NHPX began to accumulate
in nucleoli and the signal in speckles decreased, whereas the
Figure 4. Separate targeting pathways 
for nuclear factors. pAL107
EYFP–NHPX and 
pAL118
ECFP–FIB were cotransfected into 
HeLa cells and fixed after (A) 1 and (B) 
24 h. (C) HeLa
EYFP–NHPX and HeLa
ECFP–FIB 
were fused to form heterokaryon using 
PEG and were fixed at 15 min after 
fusion. To show the relative distribution 
of EYFP and ECFP components in each 
nucleus, the central panel shows the 
same two nuclei within a heterokaryon 
as the side panels, but in the opposite 
fluorescence channels. Arrowheads 
indicate CBs, arrows indicate nucleoli, 
and broken arrows indicate speckles; 
dotted ovals outline nuclei in the 
heterokaryon in the central panel.
Bars, 5  m. 
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ECFP–FIB remained specifically in nucleoli, and both pro-
teins were detected in CBs (unpublished data). After one cell
cycle, EYFP–NHPX and ECFP–FIB both quantitatively
colocalized in the dense fibrillar component inside nucleoli
and in CBs (Figs. 1 A and 4 B, arrowhead indicates CB, ar-
row indicates nucleolus, broken arrow indicates speckles;
unpublished data). Therefore, the transient presence of
newly expressed NHPX in nuclear speckles is not explained
by its association with U3 snoRNP.
The differential timing in the nucleolar entry of NHPX
and FIB is confirmed by analysis of heterokaryons formed
between HeLa
 
ECFP–FIB
 
 and HeLa
 
EYFP–NHPX
 
 stable cell lines
(Fig. 4 C). Formation of heterokaryons between two cell
lines expressing FP-tagged proteins allows the gradual intro-
duction of EYFP–NHPX into the HeLa
 
ECFP–FIB
 
 cells and
vice versa (Sleeman et al., 2001). The advantages of using
this heterokaryon approach are that it minimizes the possi-
ble effect of overexpression that can occur in both microin-
jection and transient transfection assays, and allows the dy-
namic exchange of two fluorophores to be observed under
the same conditions. ECFP–FIB accumulated directly in
nucleoli as soon as 15 min after fusion, whereas EYFP–
NHPX accumulated instead in speckles at the same time
(Fig. 4 C, arrowheads indicate CBs, arrows indicate nucleoli,
broken arrows indicate speckles; unpublished data). There-
fore, the NHPX protein detected in speckles is unlikely to be
associated with U3 snoRNP.
The expression of exogenous NHPX raises the possibility
that the target RNAs it binds to may be upregulated, and
thereby results in the observed temporal sequence of nuclear
localization. Therefore, we investigated the in vivo localiza-
tions of U3 and U4 RNAs in the HeLa cells that were mi-
Figure 5. Localization of endogenous snRNPs and snoRNPs. pAL107
EYFP–NHPX was microinjected into HeLa cells and fixed after (A and C) 2 
and (B and D) 24 h. The cells were then counterstained with antisense 2 -O-methyl RNA (A and B) U3 and (C and D) U4 and anti-SC35 to 
show the location of speckles. Arrowheads indicate CBs, arrows indicate nucleoli, and broken arrows indicate speckles. Bars, 5  m. 
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croinjected with pAL107
 
EYFP–NHPX
 
 using complementary 2
 
 
 
-
 
O
 
-methyl antisense RNAs (Fig. 5; for review see Lamond,
1993). The U3 in microinjected cells remained localized in
the dense fibrillar component of nucleoli and CBs at both
early and late time points, similar to control, nonmicroin-
jected cells (Fig. 5 A and B, arrowhead indicates CB, arrow
indicates nucleolus, broken arrow indicates speckles; unpub-
lished data). The U4 snRNA was detected in speckles and
CBs in both the microinjected cells at different time points
and in control, nonmicroinjected cells (Fig. 5, C and D).
Figure 6. Reciprocal movement of nucleolar proteins SmB and NHPX. HeLa
EYFP–NHPX and HeLa
ECFP–SmB were fused to form heterokaryon 
using PEG and were fixed at different time points: 0 h (A); 0.5 h (B); 2 h (C); 4 h (D); and 36 h (E). Panel representation as of Fig. 4 C. 
Arrowheads indicate CBs, arrows indicate nucleoli, and broken arrows indicate speckles; dotted ovals outline nuclei of the heterokaryon in 
the central panel. Bars, 5  m. 
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Because the localization of U3 and U4 remained unaltered,
the differential localization of NHPX at different time
points is likely not due to the movement or relocalization of
either of these NHPX target RNAs. These data are consis-
tent with NHPX binding U4 snRNA in speckles and U3
snoRNA in the nucleolus. However, we cannot exclude that
NHPX also binds to different and/or unknown target RNAs
at the different nuclear structures.
 
Reciprocal movement of nuclear proteins
 
The NHPX pathway appears complementary to that previ-
ously described for Sm proteins (Fig. 6; Sleeman and La-
mond, 1999a; Sleeman et al., 2001). By making heterokary-
ons between HeLa
 
ECFP–SmB
 
 and HeLa
 
EYFP–NHPX
 
, we observed that
EYFP–NHPX entered into speckles directly, whereas ECFP–
SmB accumulated specifically in CBs shortly after fusion (Fig.
6, A and B; arrowheads indicate CBs, arrows indicate nucle-
oli, broken arrows indicate speckles). At 2 h after fusion,
ECFP–SmB remained in CBs, whereas the EYFP–NHPX sig-
nal inside nucleoli increased (Fig. 6 C, arrows indicate nucle-
oli). In some cells, ECFP–SmB was also detected inside nucle-
oli, as previously reported (Fig. 6 D; Sleeman and Lamond,
1999a; Sleeman et al., 2001). At later time points (
 
 
 
36 h),
the ECFP–SmB signal in speckles increased whereas the
EYFP–NHPX signal in speckles decreased to a very low/unde-
tectable level (Fig. 6 E; unpublished data). Therefore, we con-
clude that both nuclear pathways, though operating in differ-
ent directions, function simultaneously inside a single cell
nucleus. The pathways can also be observed by live cell imag-
ing over a period of 12 h (unpublished data). This demon-
strates the directed movement of proteins between separate,
membrane free nuclear compartments.
 
Newly expressed NHPX localizes to speckles
 
We next investigated whether the directed movement of
NHPX is either restricted to newly synthesized proteins, or
whether it is a reversible relocation of existing proteins (Fig.
7). To test this, pAL214
 
ECFP–NHPX
 
 was transfected into HeLa
cells and left for 24 h, such that ECFP–NHPX was already
accumulated in nucleoli and CBs before microinjection of
pAL107
 
EYFP–NHPX
 
. Microinjection of pAL107
 
EYFP–NHPX
 
 pro-
vided a pulse of newly synthesized EYFP–NHPX that accu-
mulated in splicing speckles and CBs, whereas the previously
expressed ECFP–NHPX accumulated instead in nucleoli
and CBs (Fig. 7 A; arrowhead indicates CB, arrow indicates
nucleolus and broken arrow indicates speckles). Gradually,
EYFP–NHPX appeared in nucleoli, whereas the signal in
speckles subsided. The nucleolar pattern of ECFP–NHPX
remained unaltered after microinjection of pAL107
 
EYFP–NHPX
 
(Fig. 7 B, arrow indicates nucleolus). At 24 h postmicroin-
jection, EYFP–NHPX completely colocalized with the exist-
ing ECFP–NHPX (Fig. 7 C, arrowhead indicates CB, arrow
indicates nucleolus). These data indicate that only newly
synthesized NHPX accumulates in splicing speckles, and
further argue that this association is transient. Thus, the
presence of NHPX in speckles is likely not a result of protein
relocation due to exogenous expression.
To test further whether or not pools of NHPX in speckles
and nucleoli interchange, we generated micronuclei by treat-
ing the HeLa
 
EYFP–NHPX
 
 cells with the spindle-disrupting drug
Figure 7. Newly expressed NHPX localizes to speckles. HeLa cells were transfected with pAL214
ECFP–NHPX for 24 h before microinjecting 
pAL107
EYFP–NHPX and the microinjected cells were fixed after 1.5 h (A), 4 h (B), and 24 h (C), and counterstained with anti-SC35 to denote 
speckles. Arrowheads indicate CBs, arrows indicate nucleoli, and broken arrows indicate speckles. Bars, 5  m. 
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colcemid (Fig. 8). Colcemid inhibits the progress of mitosis
and renders the segregation of chromosomes into many mi-
cronuclei without preventing DNA replication, mRNA
transcription, splicing, and protein translation (Ferreira et
al., 1997). Nucleoli are assembled only on the nucleolar or-
ganizer regions in 5 out of 23 chromosomes in human nu-
clei (Introduction), and therefore the colcemid treatment al-
lows the generation of a subset of micronuclei without
nucleoli. To locate those micronuclei, we screened with an
antibody specific for nucleolar antigen B23. If the two pools
of NHPX in splicing speckles and nucleoli freely exchange,
NHPX originally from nucleoli would be expected by de-
fault to accumulate back in splicing speckles in the micronu-
clei lacking nucleoli. Interestingly, EYFP–NHPX does not
accumulate in splicing speckles, even in those micronuclei
lacking nucleoli (Fig. 8, arrows indicate speckles, arrowheads
indicate NHPX localizations, inset shows a micronucleus
that lacks nucleoli); instead, they are localized in spot-like
structures that also contain the snoRNP protein FIB, but
not the CB marker coilin (unpublished data). Microinjec-
tion of pAL107
 
EYFP–NHPX
 
 into colcemid-treated parental
HeLa cells showed the same temporal sequence of localiza-
tion in speckles prior to nucleoli as seen for untreated cells
(unpublished data). Therefore, this differential localization
is apparently not a result of colcemid modifying the NHPX
pathway and the pools of NHPX localized in splicing speck-
les and nucleoli appear not to interchange.
 
The NHPX pathway is unidirectional
 
The noncycling behavior of NHPX between speckles and
nucleoli prompted us to further investigate the directionality
of the localization pathway. We performed fluorescence loss
 
in photobleaching (FLIP) analyses of different nuclear struc-
tures in the HeLa
 
EYFP–NHPX
 
 cells in which one area of the cell
is repeatedly bleached while collecting images of the entire
cell (Fig. 9). If fluorescent molecules from other regions of
the cell diffuse into the bleached area (Fig. 9, white circle in-
dicates bleach zone), loss of fluorescence will occur from
both places, indicating that the regions are connected (for
review see Reits and Neefjes, 2001). First, we tested whether
NHPX inside speckles is moving into the nucleolus (Fig. 9
A, a and c). The positions of speckles were defined by
DsRED-U1A in live cells (Fig. 9 A, b and d). The fluores-
cence intensity of EYFP–NHPX in speckles outside the
bleached region decreased, indicating that NHPX diffuses
between these nuclear domains (Fig. 9 A, curve b). In com-
parison, the signals inside nucleoli only showed a minor de-
crease (Fig. 9 A, curve a). This is consistent with the ex-
pected movement of NHPX from speckles to nucleoli. The
small change in nucleolar fluorescence may be because the
directed movement of NHPX from speckles to nucleoli is
slow (hours) compared with the experimental time (
 
 
 
15
min), and/or because it accounts only for a small fraction of
the total NHPX signal in nucleoli. However, repeated pho-
tobleaching of the nucleolus (Fig. 9 B, white circle indicates
bleach zone) resulted in the immediate loss of signal in
neighboring nucleoli, indicating that the nucleolar pool of
NHPX can cycle between different nucleoli (Fig. 9 B, curve
e). The constant level of fluorescence observed in the speck-
les in the same experiment further strengthens the argument
in favor of a unidirectional movement of NHPX from
speckles to nucleoli (Fig. 9 B, curve f).
The difference in fluorescence intensity between speck-
les and nucleoli raises the possibility that the flow from
Figure 8. NHPX does not accumulate in speckles 
in micronuclei lacking nucleoli. (A) HeLa
EYFP–NHPX 
cells were fixed after treating with colcemid for
31 h and counterstained with anti-SC35 to denote 
speckles and anti-B23 to denote nucleoli. Arrows 
indicate speckles, whereas arrowheads indicate 
the locations of EYFP–NHPX; dotted ovals outline 
the micronuclei. Bar, 5  m. 
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nucleoli to speckles was not observable in the HeLa
 
EYFP–
NHPX
 
 cells. To address this, we performed FLIP analysis on
heterokaryons formed between HeLa
 
EYFP–NHPX
 
 cells and
the parental HeLa cells (Fig. 9 C). The locations of nucle-
oli in the recipient nuclei were positioned both by phase
contrast microscopy and by the absence of splicing factor
U1A. Shortly after the fusion, as shown previously (Figs. 4
C and 6, A–E), EYFP–NHPX first appeared in splicing
speckles but was absent from nucleoli in the recipient nu-
clei. Repeated photobleaching inside the nucleoli did not
change the fluorescence level of EYFP–NHPX inside the
speckles of the recipient nuclei (Fig. 9 C, curve i, white
circle indicates bleach zone). Therefore, NHPX either
does not cycle from nucleoli to speckles, or else does so at
a rate/level that cannot be detected in this assay. In sum-
mary, the photobleaching analyses, combined with the
other data presented here, suggest a unidirectional move-
ment of NHPX from splicing speckles to nucleoli. How-
ever, pools of EYFP–NHPX appear freely diffusible be-
tween separate components of the same nuclear structure,
indicating the regulated entry of nuclear proteins into dif-
ferent domains inside the nucleus.
 
The progression of NHPX from speckles to nucleoli is 
dependent on Pol II, but not Pol I transcription
 
Next, we tested whether the progression of NHPX from
speckles to nucleoli requires gene expression, including
both Pol I and Pol II transcription (Fig. 10). We again em-
Figure 9. FLIP analysis of HeLa
EYFP–NHPX. 
A region in the (A) speckles and (B) 
nucleolus was photobleached repetitively 
every 20 s and the fluorescence inten-
sities of EYFP–NHPX were analyzed 
over 15 min. The positions of speckles 
were located in the live cells using 
DsRED-U1A that were transfected into 
the cell lines for 24 h before photobleach-
ing and the selected region for 
photobleaching were highlighted by 
the white circle in left panel. The 
fluorescence intensities of EYFP–NHPX 
in different regions of the bleached 
and nonbleached cells were com-
pared in right panel. (C) FLIP analysis 
of the newly imported EYFP–NHPX in 
speckles of the heterokaryon formed 
between HeLa
EYFP–NHPX and HeLa cells 
that were both transfected with 
pDsRED-U1A for 24 h. The position 
of the nucleolus for photobleaching 
(left panel, white circle) in the recipient 
nuclei were located by both phase 
contrast microscopy and the absence 
of DsRED-U1A. The fluorescent inten-
sities of EYFP-NHPX in speckles of 
bleached and nonbleached nuclei 
of the heterokaryon were analyzed 
and shown on the right panel. Dotted 
ovals outline nuclei in the heterokaryon. 
Bars, 5  m. 
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ployed the heterokaryon approach between HeLa
 
ECFP–FIB
 
 and
HeLa
 
EYFP–NHPX
 
 cells. At 4 h postfusion, only a small amount
of EYFP–NHPX was in speckles, whereas most accumulated
in nucleoli (Figs. 6 D and 10 A, arrowheads indicate CBs, ar-
rows indicate nucleoli, broken arrows indicate speckles). The
heterokaryons formed between HeLa
 
EYFP–NHPX
 
 and HeLa
 
ECFP–
FIB
 
 cells were subjected to transcription inhibitors targeted to
specific polymerases. Low levels of actinomycin D cause the
segregation of nucleoli and inhibit rRNA transcription, but
not pre-mRNA transcription. Newly synthesized EYFP–
NHPX moved to the speckles of recipient HeLa
 
ECFP–FIB
 
 nu-
clei, prior to accumulating in the segregated nucleoli (Fig. 10
B, arrows indicate segregated nucleoli, broken arrows indicate
speckles), suggesting that pol I transcription and/or ribosome
biogenesis is not a prerequisite for the NHPX pathway. Simi-
larly, the immunosuppressant rapamycin, which inhibits tran-
scription of a subset of ribosomal protein genes and hence ri-
bosome assembly, gave the same results (unpublished data).
 
However, when RNA pol II transcription was inhibited, ei-
ther by 
 
 
 
-amanitin or DRB, progression of the newly synthe-
sized NHPX from speckles to the nucleolus was blocked (Fig.
10 C, arrows indicate nucleoli, broken arrows indicate speck-
les; unpublished data). This suggests that one or more factors
must be continually synthesized to allow the newly imported
NHPX to move from speckles to nucleoli.
 
Discussion
 
In this study we have identified a novel nuclear pathway that
leads to the nucleolar accumulation of the NHPX protein.
The pathway was detected in multiple mammalian cultured
cell lines, including both primary and transformed cells.
NHPX was analyzed in vivo, fused to either EYFP or ECFP
fluorescent protein tags, and the resulting fusion proteins
were shown to have similar localization patterns and RNA
binding specificities to the endogenous NHPX. A stably
Figure 10. Transcription-dependent relocation of NHPX from speckles to nucleoli. Heterokaryon formed between HeLa
EYFP–NHPX and HeLa
ECFP–FIB 
were treated with different transcription inhibitors: control (A); Pol I inhibitor Actinomycin D (0.04  g/ml) (B); and Pol II inhibitor DRB (100  M) (C). 
Panel representation as of Fig. 4 C. Arrowheads indicate CBs, arrows indicate nucleoli, and broken arrows indicate speckles; dotted ovals outline 
nuclei of the heterokaryon in the central panel. Bars, 5  m. Novel nucleolar localization pathway for NHPX | Leung and Lamond 627
transformed HeLa cell line that expressed EYFP–NHPX was
established and used to demonstrate that, upon its initial en-
try into the nucleus, newly expressed NHPX transiently
accumulates in splicing speckles prior to a later, steady-
state accumulation in nucleoli. Further characterization of-
HeLa
EYFP–NHPX cells indicated that the NHPX protein in
speckles was not associated with U3 snoRNP and required
RNA pol II transcription for efficient relocation to nucleoli.
Additional photobleaching experiments showed that the nu-
cleolar pool of NHPX did not interchange with the pool in
nuclear speckles, suggesting a unidirectional pathway.
Our recent proteomic analysis of nucleoli isolated from
cultured HeLa cells shows that they contain  270 differ-
ent proteins (Andersen et al., 2002). So far there has been
no nucleolar targeting motif identified common to all of
these factors and it seems likely that multiple, parallel nu-
cleolar localization pathways can operate. Nonetheless,
analyses of proteins that show a steady-state accumulation
in nucleoli have shown that they usually move rapidly into
the nucleolus when they enter the nucleus. This is illus-
trated here by the rapid nucleolar accumulation of EYFP–
FIB when it is transiently expressed in vivo (Fig. 4). The
finding that newly expressed NHPX accumulates in nu-
clear speckles transiently before accumulating specifically
in the nucleolus defines a new localization pathway for nu-
cleolar proteins. It is interesting to compare this with the
recently reported pathway for nucleolar localization of
snoRNAs, which showed that multiple snoRNAs accumu-
late in CBs prior to nucleoli upon initial entry into the nu-
cleus (Narayanan et al., 1999a, 1999b; Verheggen et al.,
2001). However, none of the snoRNAs showed a transient
accumulation in speckles, consistent with our finding that
the snoRNP protein FIB also does not transiently accumu-
late in speckles prior to nucleoli (Fig. 4). We also observed
that NHPX localizes to CBs as well as speckles upon its
initial entry into the nucleus, but unlike its transient asso-
ciation with speckles, NHPX is also detected in CBs at
later stages of expression when the bulk of the protein is
concentrated in nucleoli. At present, we cannot distinguish
whether NHPX accumulates in CBs prior to speckles, or in
both structures at the same time. However, the CB associa-
tion does not appear to be obligatory for the NHPX local-
ization pathway because a similar transient association with
speckles prior to nucleolar accumulation is observed in cell
lines lacking prominent CBs (Fig. 3 B). However, similar
molecular events may occur either within the nucleoplasm
or in CBs that are too small to detect.
It is also interesting to compare the NHPX pathway with
the recently identified nuclear pathway for splicing snRNPs
where FP-tagged snRNP Sm proteins accumulate in CBs,
and nucleoli, prior to speckles, upon their initial nuclear en-
try (Sleeman and Lamond, 1999a; Sleeman et al., 2001).
Therefore, this pathway appears to be complementary to
that of NHPX. By analyzing heterokaryons formed between
separate stable HeLa cell lines expressing EYFP–NHPX and
ECFP–SmB, we could show that both these complementary
pathways can operate simultaneously within the same nuclei
(Fig. 6). These data confirm the specificity of the pathways
and highlight the dynamic mechanisms operating to orga-
nize the distribution of proteins and RNPs in the nucleus.
The results also point to the localization specificity of the
separate subnuclear bodies, including nucleoli, CBs, and
speckles, although they are not enclosed by membranes.
In order to answer why NHPX shows the observed transient
accumulation in speckles prior to nucleoli, it may be important
to consider that it is specifically newly expressed and imported
NHPX protein that is detected in speckles. Several experiments
showed that NHPX does not localize to speckles by default, and
that the nucleolar pool of NHPX does not cycle continually to
and from speckles. For example, in micronuclei that lack NOR-
containing chromosomes (and hence do not have nucleoli),
NHPX does not accumulate back in speckles or colocalize with
splicing factors (Fig. 8). FLIP photobleaching experiments also
showed that whereas nucleolar EYFP–NHPX can exchange
rapidly between separate nucleoli within the same nucleus, little
or no exchange occurs with the pool of NHPX in speckles (Fig.
9). This contrasts with the behavior of the nucleolar protein
PSP1, which was recently shown to cycle continually between
nucleoli and paraspeckles (Fox et al., 2002).
Our data strongly indicate that the association of NHPX
with speckles is a temporal phenomenon linked to the entry of
newly expressed NHPX into the nucleus. For example, tran-
sient expression of EYFP–NHPX in HeLa cells expressing
ECFP–NHPX, which already accumulated in nucleoli, shows
a transient accumulation of the EYFP–NHPX in speckles be-
fore it later colocalizes quantitatively with the existing nucle-
olar ECFP–NHPX (Fig. 7). Also, when the HeLa
EYFP–NHPX
cells undergo mitosis, EYFP–NHPX immediately relocalizes to
the reforming nucleoli during telophase and does not accumu-
late in speckles in the postmitotic nuclei (Fig. 2). Therefore,
the speckles association is not a result of nuclear import of
NHPX per se, but rather relates to an effect specific for newly
expressed protein. We propose that a likely explanation for this
behavior of NHPX could be related to it having a function re-
quired for the assembly or maturation of some form of nuclear
protein or RNP complex, prior to its subsequent stable associa-
tion with U3 and/or other nucleolar snoRNPs. This could im-
ply either that the affinity of NHPX for different target RNAs
changes after it enters the nucleus for the first time or that its
access to bind snoRNA targets is initially restricted.
Based upon the results of previous biochemical studies on
the structure and binding specificity of NHPX, the U4 sn-
RNA is a possible candidate target for NHPX in speckles.
NHPX binds U4 snRNA in vitro via the 5  stem loop se-
quence (Nottrott et al., 1999; Vidovic et al., 2000). Consis-
tent with this idea, U4 snRNA has been localized to speckles
in HeLa cells by hybridization experiments (Carmo-Fonseca
et al., 1992; Fig. 5). The fact that we show here that EYFP-
NHPX likely interacts in vivo with a form of U4 snRNA that
is not stably associated with U6 snRNA suggests that NHPX
may transiently interact in speckles with an immature form of
U4 snRNP (Fig. 1 E). The observed requirement for gene ex-
pression in order for NHPX to move from speckles to nucleoli
might reflect a requirement for other factors to be expressed to
allow NHPX to complete its transient role in speckles (Fig.
10). Whether this is connected to U4 snRNP assembly and/or
some other events remains to be established. Future studies
will aim to analyze further the molecular mechanism involved
in the novel nucleolar localization pathway detected for
NHPX and to establish what biological role this may play.628 The Journal of Cell Biology | Volume 157, Number 4, 2002
Materials and methods
Plasmid constructs
NHPX cDNA (gi:26185777) was isolated for PCR amplification from
Marathon-Ready HeLa library (CLONTECH Laboratories, Inc.) using spe-
cific primers with BglII and KpnI restriction site attached on the 5  and 3 
primer, respectively. The amplified fragment was subsequently cloned to
the BglII-KpnI fragment of EYFP–C1 and ECFP–C1 to form pAL107
EYFP–
NHPX and pALZ14
ECFP–NHPX, respectively, and verified by DNA sequencing.
Cell culture, transfection, and establishment of stable cell line
HeLa, MCF7, HEK293, and primary fibroblast htert1787 were grown in
DME supplemented with 10% FCS and 100 U/ml penicillin and streptomy-
cin (Invitrogen). 2  g plasmid construct per 100-mm dish was used for
transfection using Effectene (QIAGEN) according to the manufacturer’s in-
struction. EYFP–NHPX and EYFP–FIB stable cell lines were generated essen-
tially as described in Sleeman et al. (2001). ECFP–SmB stable cell line
(CFPSmBE8.8) was previously described (Sleeman et al., 2001). EGFP–H2B
stable cell line was a gift from T. Kanda (The Salk Institute for Biological
Studies, La Jolla, CA) (Kanda et al., 1998). Drug treatments were carried out
as follows: Actinomycin D (0.04  g/ml, 3 h; Sigma-Aldrich); DRB (100  M,
4 h; Sigma-Aldrich);  -amanitin (40  M, 4 h; Sigma-Aldrich); and colcemid
(0.5  g/ml, 31 h; Sigma-Aldrich).
FACS analysis
Parental HeLa and HeLa
EYFP–NHPX cells were harvested by trypsinization,
and fixed in 70% ethanol for 3 h at 4 C. Cells were stained with PI (25  g/
ml) containing RNase A (100  g/ml). Fluorescence was measured using a
FACScan (Becton Dickinson). Cell debris and fixation artifacts were gated
out. Data analysis was done using Cell Quest software (Becton Dickinson).
Immunoprecipitation and immunoblotting
For immunoprecipitation, 100  g protein G Sepharose (Amersham Phar-
macia Biotech) was preincubated with 10  g anti-GFP antibodies (Roche).
Extracts were prepared using nuclear lysis buffer (Sleeman et al., 2001). Ex-
tracts were precleared with 100  g protein G Sepharose and then incu-
bated with antibody-bound protein G Sepharose for 16 h. Beads were then
washed three times with the lysis buffer, and bound RNAs were released
by Proteinase K (2.24 mg/ml) in extraction buffer (0.63% SDS, 26.25 mM
EDTA, 26.25 mM Tris-HCl, pH 8.0, 0.28 mg/ml yeast tRNA) for 45 min at
65 C. RNAs were precipitated by adding 7 vol of EtOH/NH4OAc (86%
EtOH, 0.57 M NH4OAc), and washed once with 70% EtOH. Northern hy-
bridizations were done by standard procedures (Lamond et al., 1989).
For immunoblotting, protein samples were separated by 4–12% Bis-Tris
gels (Novex), and subsequently transferred onto nitrocellulose membrane
using a submarine system (Novex). After blocking with 5% milk powder in
PBS 0.05% Tween-20, the membranes were incubated with either rabbit
anti-NHPX R86 (1:100; Chang et al., 1999) or mouse monoclonal anti-
GFP (1:1,000; Roche), and the bound antibody was then probed using
anti–rabbit HRP (1:2,000; Pierce Chemical Co.) and anti–mouse HRP con-
jugate, respectively (1:5,000; Pierce Chemical Co.) in PBS containing 5%
milk powder and 0.05% Tween-20, and detected via chemiluminescence
with ECL Plus (Amersham Pharmacia Biotech).
Immunostaining and 2 -O-methyl RNA hybridization
Cells grown on coverslips were washed in PBS and fixed for 10 min in
3.7% (wt/vol) paraformaldehyde in CSK buffer (10 mM Pipes, pH 6.8, 10
mM NaCl, 300 mM sucrose, 3 mM MgCl2, 2 mM EDTA) at RT, permeabi-
lized with 1% Triton X-100 in PBS for 10 min at room temperature,
mounted onto glass slides using VectorShield (Vector Lab), and imaged
as described below. Antibodies used were anti-FIB monoclonal 72b9
(1:10; Turley et al., 1993); anti-NHPX peptide antibody R86 (1:100;
Chang et al., 1999); anti-SC35 monoclonal (1:500; Sigma-Aldrich); anti-
coilin 204/10 (1:300; Bohmann et al., 1995); anti-B23 (1:75; Santa Cruz
Biotechnology); and TRITC-, Texas red–, and Cy5-conjugated secondary
antibodies (Jackson Laboratories). Before being mounted on slides, cov-
erslips were incubated with 1  M DAPI (Sigma-Aldrich) for 30 s to stain
DNA. Fluorescence microscopy of fixed cells was carried out using a
100  NA 1.4 Plan-Apochromat objective. Three-dimensional images
and sections were recorded either on a LSM410 Confocal microscope
(ZEISS) or on a Zeiss DeltaVision Restoration microscope (Applied Preci-
sion, Inc.). Images presented here are maximal intensity projections of
the entire nuclear fluorescence.
For 2 -O-Methyl RNA hybridization (Carmo-Fonseca et al., 1992),
cells were permeabilized with 0.5% Triton X-100 in CSK buffer contain-
ing Complete (Roche) on ice for 3 min, and were then fixed in freshly
prepared 3.7% paraformaldehyde in CSK buffer for 10 min at room tem-
perature. Cells were washed three times in PBS, one time with 6   SSPE,
and prehybridized with 6   SSPE/5   Denhardt’s solution containing
yeast tRNA (0.5 mg/ml) for 15 min. Cells were then hybridized with the
same buffer with biotinylated 2 -O-methyl antisense oligonucleotide
probe (2  M) for 30 min, and then were washed three times with 6  
SSPE and rinsed with avidin wash buffer (0.03 M Hepes, pH 7.9, 0.15 M
KCl, 0.05% Tween-20, 1% donkey serum) before incubating with Texas
red–conjugated avidin DCS (Vector Labs) at 2  g/ml for 30 min. They
were then washed and mounted on slides for microscopic studies as
above. (U3 probe 1011: 5  – *C*CUUUCGGUGCUC*C*C – 3 ;  U4
probe 1012: 5  – *C*CUGCCACUGCGCAAAGCU*C*C – 3 ; * denotes
biotinylated sites).
Mitotic studies of living cells
Cells were grown on 40-mm glass coverslips (Intracel) in medium contain-
ing 200  g/ml G418. Cells were maintained at 37 C by use of a closed-
system perfusion chamber (Bioptech) in DME media (20 mM Hepes, with-
out Phenol red; Invitrogen). Images were collected using the 100  NA 1.4
Plan-Apochromat objective on the Zeiss-DeltaVision Restoration micro-
scope. For each nucleus, 20–30 optical sections in the z-axis were re-
corded. The Hg lamp was attenuated with a 0.5-OD neutral density filter,
and images were recorded every 3 min over a time period of 2 h (3   3
binning). Time-lapse images were viewed as maximal intensity projections
of each time point (SoftWoRx; Applied Precision, Inc.).
Microinjection and heterokaryon formation
For microinjection, pAL107 was diluted to 20  g/ml with injection buffer
(100 mM glutamic acid, pH 7.2 [with citric acid], 140 mM KOH, 1 mM
MgSO4, and 1mM DTT) prior to injection into living cells using an Eppen-
dorf 5242 microinjector. For heterokaryon formation, two different cell
lines expressing fluorescent proteins were mixed in a ratio of 1:1 in 100-
mm diameter petri dishes containing coverslips and cultured until 80–90%
confluent. The culture medium was drained, and 1.5 ml of 50% Polyethyl-
ene Glycol (PEG hybrimax; Sigma-Aldrich) was added. The dishes were
rocked gently for 90 s and washed thoroughly by several changes of fresh
culture medium (a modification of Sleeman et al. 2001).
Photobleaching analysis
Cells were grown on 42-mm glass coverslips (no. 1; Helmut Sauer) in
medium containing 200  g/ml G418. Cells were maintained at 37 C by
use of a closed perfusion chamber (Bachofer) in DME media (20 mM
Hepes, no Phenol red; Invitrogen). Photobleaching experiments were
carried out on a Zeiss 510 confocal laser scanning microscope equipped
with an argon-krypton laser (ZEISS). The 488-nm laser and a 63  plan
Apolens with a 1.4 NA and a laser power of 2.5% was used for image
acquisition, and 25% was used for photobleaching. An area of 16   16
pixels was bleached with an iteration of 250 (duration of bleach was
3 s). An image was collected after every bleaching event, with 20-s inter-
vals between each bleaching event over a period of 15 min. To locate
splicing speckles in vivo, plasmid pDsRED-U1A was transfected into the
cells 24–36 h before imaging. Speckles were defined by red fluores-
cence, whereas nucleoli were defined by both phase contrast and the
absence of U1A.
Online supplemental material
Fig. S1 (available at http://www.jcb.org/cgi/content/full/200201120/DC1)
depicts immunofluorescence labeling of HeLa cells using anti-NHPX anti-
bodies either with (A) or without (B) transient transfection with pAL107
EYFP–
NHPX. Panel A is identical to Fig. 1 B in the text.
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